Piperazine → N-(1-Methylethyl)-3-(1-piperazinyl)-2-pyrazinamine
Reaction equation
Cl[C:2]1[C:7]([NH:8][CH:9]([CH3:11])[CH3:10])=[N:6][CH:5]=[CH:4][N:3]=1.[NH:12]1[CH2:17][CH2:16][NH:15][CH2:14][CH2:13]1>C1(C)C(C)=CC=CC=1.Cl>[CH3:10][CH:9]([NH:8][C:7]1[C:2]([N:12]2[CH2:17][CH2:16][NH:15][CH2:14][CH2:13]2)=[N:3][CH:4]=[CH:5][N:6]=1)[CH3:11]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
A solution of 2-chloro-3-(1-methylethylamino)pyrazine (PREPARATION 6, 1.6 g) and piperazine (4.3 g) in xylene (10 ml) is refluxed for 26 hr. The mixture is cooled to 0° and diluted with concentrated hydrochloric acid (8 ml). The xylene is decanted and ether is added and also decanted from the salts. The salts are diluted with excess aqueous sodium hydroxide (5%) and dichloromethane. The phases are separated. The aqueous phase is extracted three more times with dichloromethane. The combined organic extracts are dried over sodium sulfate and concentrated to give a liquid mixture which is flash chromatographed on silica gel eluting with methanol/chloroform (5/95). The appropriate fractions are pooled and concentrated to give the title compound, NMR (CDCl3) 1.27, 1.83, 3.04, 4.12, 4.78, 7.49 and 7.72 δ.
Workup
- temperatureThe mixture is cooled to 0°
- customThe xylene is decanted
- additionether is added
- customalso decanted from the salts
- additionThe salts are diluted with excess aqueous sodium hydroxide (5%) and dichloromethane
- customThe phases are separated
- extractionThe aqueous phase is extracted three more times with dichloromethane
- dry with materialThe combined organic extracts are dried over sodium sulfate
- concentrationconcentrated
- customto give a liquid mixture which
- customchromatographed on silica gel eluting with methanol/chloroform (5/95)
- concentrationconcentrated
Sources & evidence
- ORD record
- ord-15d9914829f64caab789814b110946f3
- Source dataset
- uspto-grants-1997_02
- Patent number
- US05599930
Reaction notes
Loading…